{
  "combination": {
    "prompt": "direct_mcode_evidence_based_concise",
    "model": "deepseek-coder"
  },
  "success": true,
  "cv_average_score": 1.0,
  "cv_std_score": 0.0,
  "fold_scores": [
    1.0,
    1.0,
    1.0
  ],
  "cv_folds": 3,
  "total_trials": 3,
  "total_elements": 52,
  "errors": [],
  "timestamp": "2025-09-19T20:36:57.642592",
  "metrics": {
    "precision": 1.0,
    "recall": 1.0,
    "f1_score": 1.0
  },
  "predicted_mcode": [
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Conditions: Breast Cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "breast cancer patient treated with adjuvant chemotherapy"
    },
    {
      "element_type": "CancerTreatment",
      "code": "367336001",
      "display": "Chemotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "breast cancer patient treated with adjuvant chemotherapy"
    },
    {
      "element_type": "Patient",
      "code": "424144002",
      "display": "Current chronological age (observable entity)",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "minimumAge: 18 Years"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "patients with early breast cancer"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387608008",
      "display": "Chemotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "adjuvant chemotherapy with AC (adriamycin-cyclophosphamide) or CAF (adriamycin-cyclophosphamide-5-fluorouracil) combinations"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387608008",
      "display": "Chemotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "during the adjuvant chemotherapy"
    },
    {
      "element_type": "CancerTreatment",
      "code": "108606009",
      "display": "Doxorubicin",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "AC (adriamycin-cyclophosphamide) or CAF (adriamycin-cyclophosphamide-5-fluorouracil) combinations"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387460002",
      "display": "Cyclophosphamide",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "AC (adriamycin-cyclophosphamide) or CAF (adriamycin-cyclophosphamide-5-fluorouracil) combinations"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387460002",
      "display": "Cyclophosphamide",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "CAF (adriamycin-cyclophosphamide-5-fluorouracil) combinations"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387460002",
      "display": "Cyclophosphamide",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "AC (adriamycin-cyclophosphamide)"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387608008",
      "display": "Chemotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "adjuvant chemotherapy"
    },
    {
      "element_type": "CancerTreatment",
      "code": "108606009",
      "display": "Doxorubicin",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "AC (adriamycin-cyclophosphamide)"
    },
    {
      "element_type": "CancerTreatment",
      "code": "108606009",
      "display": "Doxorubicin",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "CAF (adriamycin-cyclophosphamide-5-fluorouracil)"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Adjuvant Chemotherapy for Breast Cancer Patients"
    },
    {
      "element_type": "CancerTreatment",
      "code": "367336001",
      "display": "Chemotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients"
    },
    {
      "element_type": "CancerTreatment",
      "code": "71388002",
      "display": "Procedure",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.8,
      "evidence_text": "Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Breast Cancer Female"
    },
    {
      "element_type": "PatientSex",
      "code": "248153007",
      "display": "Female",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Breast Cancer Female"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Invasive breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Histologic diagnosis of invasive breast cancer or ductal carcinoma in situ."
    },
    {
      "element_type": "CancerCondition",
      "code": "92546004",
      "display": "Ductal carcinoma in situ of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Histologic diagnosis of invasive breast cancer or ductal carcinoma in situ."
    },
    {
      "element_type": "PatientDemographics",
      "code": "184099003",
      "display": "Age 18 years or older",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Age > 18 years."
    },
    {
      "element_type": "PatientDemographics",
      "code": "248152002",
      "display": "Female",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Female gender."
    },
    {
      "element_type": "CancerTreatment",
      "code": "367336001",
      "display": "Chemotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients who have received neoadjuvant chemotherapy for their current diagnosis."
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "to in aid removal of breast cancers"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "breast cancer locator (BCL) surgical device to in aid removal of breast cancers"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "breast cancers"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "HER2 positive breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "HER2-positive Breast Cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Male breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Male Breast Cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Stage IV breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Stage IV Breast Cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "HER2 positive breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients with HER-2+ Stage IV breast cancer that have been maximally treated and not in a complete remission"
    },
    {
      "element_type": "TNMStage",
      "code": "399537006",
      "display": "Stage IV breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients with HER-2+ Stage IV breast cancer that have been maximally treated and not in a complete remission"
    },
    {
      "element_type": "PatientDemographics",
      "code": "424144002",
      "display": "Age 18 years or older",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Subjects must be > 18 years old"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387018007",
      "display": "Trastuzumab therapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients can be receiving trastuzumab and/or hormonal therapy and/or bisphosphonates"
    },
    {
      "element_type": "CancerTreatment",
      "code": "373871005",
      "display": "Hormonal therapy for cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients can be receiving trastuzumab and/or hormonal therapy and/or bisphosphonates"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387132000",
      "display": "Bisphosphonate therapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients can be receiving trastuzumab and/or hormonal therapy and/or bisphosphonates"
    },
    {
      "element_type": "CancerCondition",
      "code": "94260004",
      "display": "Brain metastasis",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Active brain metastasis"
    },
    {
      "element_type": "CancerCondition",
      "code": "128348002",
      "display": "Skeletal metastasis",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Skeletal or bone-only disease that is measurable by FDG PET imaging will also be allowed"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "HER2-positive breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "patients with HER2-positive stage IV breast cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "315025001",
      "display": "Stage IV breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "patients with HER2-positive stage IV breast cancer"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387608007",
      "display": "Cyclophosphamide",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Drugs used in chemotherapy, such as cyclophosphamide"
    },
    {
      "element_type": "CancerTreatment",
      "code": "763703003",
      "display": "T-cell immunotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "ex vivo-expanded HER2-specific T cells"
    },
    {
      "element_type": "CancerTreatment",
      "code": "418992000",
      "display": "Cancer vaccine therapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 0.9,
      "evidence_text": "Vaccines made from HER2 peptides may help the body build an effective immune response"
    },
    {
      "element_type": "CancerTreatment",
      "code": "418992000",
      "display": "Cancer vaccine therapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients receive HER2 peptide vaccine intradermally once weekly for 3 weeks"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387608007",
      "display": "Cyclophosphamide",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients receive cyclophosphamide IV on day -1"
    },
    {
      "element_type": "CancerTreatment",
      "code": "763703003",
      "display": "T-cell immunotherapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Patients receive ex vivo-expanded HER2 specific T-cell IV over 30 minutes on days 1, 10, and 20"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "HER2-positive breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "HER2-Positive Stage IV Breast Cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "HER2-positive breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "HER-2-Positive Breast Cancer"
    },
    {
      "element_type": "TNMStage",
      "code": "444256004",
      "display": "Stage IV breast cancer",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Stage IV Breast Cancer"
    },
    {
      "element_type": "CancerTreatment",
      "code": "108290001",
      "display": "Adoptive T-cell therapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Adoptive T-Cell Therapy With HER-2/Neu (HER-2)-Specific Memory CD8+ T Lymphocytes"
    },
    {
      "element_type": "CancerTreatment",
      "code": "387317001",
      "display": "Cyclophosphamide",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Cyclophosphamide After Vaccine Therapy"
    },
    {
      "element_type": "CancerTreatment",
      "code": "418992009",
      "display": "Peptide vaccine therapy",
      "system": "http://snomed.info/sct",
      "confidence_score": 1.0,
      "evidence_text": "Peptide Vaccine in Patients With Advanced Stage HER-2-Positive Breast Cancer"
    }
  ]
}